Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4903)
All Articles published online
|
Apr 15, 2002 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qin LX, Tang ZY. The prognostic significance of clinical and pathological features in hepatocellular carcinoma. World J Gastroenterol 2002; 8(2): 193-199 [PMID: 11925590 DOI: 10.3748/wjg.v8.i2.193] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v8/i2/193.htm |
| Number | Citing Articles |
| 1 |
Shi-Min Luo, Li-Jian Liang, Jia-Ming Lai. Effects of recombinant human growth hormone on remnant liver after hepatectomy in hepatocellular carcinoma with cirrhosis. World Journal of Gastroenterology 2004; 10(9): 1292-1296 doi: 10.3748/wjg.v10.i9.1292
|
| 2 |
Geng Tian, Ji-Lin Yi, Ping Xiong. Antitumor immunopreventive effect in mice induced by DNA vaccine encoding a fusion protein of α-fetoprotein and CTLA4. World Journal of Gastroenterology 2004; 10(2): 200-204 doi: 10.3748/wjg.v10.i2.200
|
| 3 |
Hansheng Liu, Aiqun Zhang, Niansong Qian, Lijie Gao, Lining Xu, Wenzhi Zhang, Kai Jiang, Shouwang Cai, Zhiqiang Huang, Jiahong Dong. Postoperative Transarterial Chemoembolization Benefits Patients with High γ-Glutamyl Transferase Levels after Curative Hepatectomy for Hepatocellular Carcinoma: A Survival Stratification Analysis. The Tohoku Journal of Experimental Medicine 2012; 227(4): 269 doi: 10.1620/tjem.227.269
|
| 4 |
Andrea Horvath, Aniko Folhoffer, Peter Laszlo Lakatos, Judit Halász, Gyorgy Illyés, Zsuzsa Schaff, Monika Beatrix Hantos, Kornelia Tekes, Ferenc Szalay. Rising plasma nociceptin level during development of HCC: A case report. World Journal of Gastroenterology 2004; 10(1): 152-154 doi: 10.3748/wjg.v10.i1.152
|
| 5 |
Dai Hoon Han, Sung Hoon Choi, Eun Jung Park, Dae Ryong Kang, Gi Hong Choi, Jin Sub Choi. Surgical outcomes after laparoscopic or robotic liver resection in hepatocellular carcinoma: a propensity‐score matched analysis with conventional open liver resection. The International Journal of Medical Robotics and Computer Assisted Surgery 2016; 12(4): 735 doi: 10.1002/rcs.1714
|
| 6 |
Dong Do You, Dong Goo Kim, Chang Ho Seo, Ho Joong Choi, Young Kyung Yoo, Yong Gyu Park. Prognostic factors after curative resection hepatocellular carcinoma and the surgeon's role. Annals of Surgical Treatment and Research 2017; 93(5): 252 doi: 10.4174/astr.2017.93.5.252
|
| 7 |
Yong‐Song Guan, Ying Hu, Yuan Liu. Multidetector‐row computed tomography in the management of hepatocellular carcinoma with transcatheter arterial chemoembolization. Journal of Gastroenterology and Hepatology 2006; 21(6): 941 doi: 10.1111/j.1440-1746.2006.04474.x
|
| 8 |
Si-Hai Chen, Qin-Si Wan, Di Zhou, Ting Wang, Jia Hu, Yu-Ting He, Hai-Liang Yuan, Yu-Qi Wang, Kun-He Zhang. A Simple-to-Use Nomogram for Predicting the Survival of Early Hepatocellular Carcinoma Patients. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00584
|
| 9 |
Zhao-Chong Zeng, Jia Fan, Zhao-You Tang, Jian Zhou, Lun-Xiu Qin, Jian-Hua Wang, Hui-Chuan Sun, Bin-Liang Wang, Jian-Ying Zhang, Guo-Liang Jiang, Yu-Qi Wang. A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus. International Journal of Radiation Oncology*Biology*Physics 2005; 61(2): 432 doi: 10.1016/j.ijrobp.2004.05.025
|
| 10 |
Xin-Da Zhou, Zhao-You Tang, Zeng-Chen Ma, Jia Fan, Zhi-Quan Wu, Lun-Xiu Qin, Jian Zhou, Yao Yu, Hui-Chuan Sun, Shuang-Jian Qiu. Twenty-year survivors after resection for hepatocellular carcinoma-analysis of 53 cases. Journal of Cancer Research and Clinical Oncology 2009; 135(8): 1067 doi: 10.1007/s00432-009-0546-z
|
| 11 |
Alpaslan Tanoglu, Ergenekon Karagoz. Predictive Role of the Neutrophil-to-Lymphocyte Ratio in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib. Asian Pacific Journal of Cancer Prevention 2014; 15(2): 1063 doi: 10.7314/APJCP.2014.15.2.1063
|
| 12 |
Young-Joo Jin, Young-Hwa Chung, Jeong A. Kim, Won Hyung Park, Danbi Lee, Dong Dae Seo, Soo Hyung Ryu, Myoung Kuk Jang, Eunsil Yu, Young Joo Lee. Factors Predisposing Metastatic Tumor Antigen 1 Overexpression in Hepatitis B Virus Associated Hepatocellular Carcinoma. Digestive Diseases and Sciences 2012; 57(11): 2917 doi: 10.1007/s10620-012-2296-z
|
| 13 |
Xiao Cui, Zhao Li, Jie Gao, Peng-Ji Gao, Yan-bing Ni, Ji-Ye Zhu. Elevated CXCL1 increases hepatocellular carcinoma aggressiveness and is inhibited by miRNA-200a. Oncotarget 2016; 7(40): 65052 doi: 10.18632/oncotarget.11350
|
| 14 |
Ning Ren, Qing-Hai Ye, Lun-Xiu Qin, Bo-Heng Zhang, Yin-Kun Liu, Zhao-You Tang. Circulating DNA level is negatively associated with the long-term survival of hepatocellular carcinoma patients. World Journal of Gastroenterology 2006; 12(24): 3911-3914 doi: 10.3748/wjg.v12.i24.3911
|
| 15 |
Li-Wang Zhang, Jun Ren, Liang Zhang, Hong-Mei Zhang, Bin Jin, Bo-Rong Pan, Xiao-Ming Si, Yan-Jun Zhang, Zhong-Hua Wang, Yang-Lin Pan, Stephen M Festein. Construction and expression of recombined human AFP eukaryotic expression vector. World Journal of Gastroenterology 2003; 9(7): 1465-1468 doi: 10.3748/wjg.v9.i7.1465
|
| 16 |
M.A. Hayat. Handbook of Immunohistochemistry and in situ Hybridization of Human Carcinomas, Volume 3 - Molecular Genetics, Liver Carcinoma, and Pancreatic Carcinoma. Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas 2005; 3: 131 doi: 10.1016/S1874-5784(05)80018-2
|
| 17 |
Ming-Chin Yu, Yun-Shien Lee, Sey-En Lin, Hsiang-Yao Wu, Tse-Ching Chen, Wei-Chen Lee, Miin-Fu Chen, Chi-Neu Tsai. Recurrence and Poor Prognosis Following Resection of Small Hepatitis B-Related Hepatocellular Carcinoma Lesions Are Associated with Aberrant Tumor Expression Profiles of Glypican 3 and Osteopontin. Annals of Surgical Oncology 2012; 19(S3): 455 doi: 10.1245/s10434-011-1946-2
|
| 18 |
Kuo-Shyang Jeng, I-Shyan Sheen, Yi-Chun Tsai. Does the Presence of Circulating Hepatocellular Carcinoma Cells Indicate a Risk of Recurrence after Resection?. The American Journal of Gastroenterology 2004; 99(8): 1503 doi: 10.1111/j.1572-0241.2004.30227.x
|
| 19 |
Juqiang Han, Xiaojie Xu, Hongzhen Qin, Anheng Liu, Zhongyi Fan, Lei Kang, Jing Fu, Jiahong Liu, Qinong Ye. The molecular mechanism and potential role of heat shock-induced p53 protein accumulation. Molecular and Cellular Biochemistry 2013; 378(1-2): 161 doi: 10.1007/s11010-013-1607-9
|
| 20 |
Makoto Nakamuta, Shusuke Morizono, Motoyuki Kohjima, Kazuhiro Kotoh, Munechika Enjoji. Baseline characterization of patients aged 70 years and above with hepatocellular carcinoma. World Journal of Gastroenterology 2005; 11(47): 7512-7514 doi: 10.3748/wjg.v11.i47.7512
|
| 21 |
Qiang Qu, Shaobin Wang, Shuguang Chen, Li Zhou, Jing-An Rui. Prognostic Role and Significance of Paraneoplastic Syndromes in Hepatocellular Carcinoma. The American Surgeon™ 2014; 80(2): 191 doi: 10.1177/000313481408000230
|
| 22 |
Dai Hoon Han, Gi Hong Choi, Kyung Sik Kim, Jin Sub Choi, Young Nyun Park, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Kwang‐Hyub Han. Prognostic significance of the worst grade in hepatocellular carcinoma with heterogeneous histologic grades of differentiation. Journal of Gastroenterology and Hepatology 2013; 28(8): 1384 doi: 10.1111/jgh.12200
|
| 23 |
Wen-jun Ma, Hai-yong Wang, Li-song Teng. Correlation analysis of preoperative serum alpha-fetoprotein (AFP) level and prognosis of hepatocellular carcinoma (HCC) after hepatectomy. World Journal of Surgical Oncology 2013; 11(1) doi: 10.1186/1477-7819-11-212
|
| 24 |
Sui-Hai Si, Jian-Min Yang, Zhi-Hong Peng, Yuan-Hui Luo, Ping Zhou. Effects of KAI1 gene on growth and invasion of human hepatocellular carcinoma MHCC97-H cells. World Journal of Gastroenterology 2004; 10(14): 2019-2023 doi: 10.3748/wjg.v10.i14.2019
|
| 25 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 151 doi: 10.1007/978-3-319-26956-6_6
|
| 26 |
Tsung‐Han Wu, Ming‐Chin Yu, Tse‐Ching Chen, Chen‐Fang Lee, Kun‐Ming Chan, Ting‐Jung Wu, Hong‐Shiue Chou, Wei‐Chen Lee, Miin‐Fu Chen. Encapsulation is a significant prognostic factor for better outcome in large hepatocellular carcinoma. Journal of Surgical Oncology 2012; 105(1): 85 doi: 10.1002/jso.22060
|
| 27 |
Dai Hoon Han, Gi Hong Choi, Jun Yong Park, Sang Hoon Ahn, Kyung Sik Kim, Jin Sub Choi, Kwang-Hyub Han. Lesson from 610 liver resections of hepatocellular carcinoma in a single center over 10 years. World Journal of Surgical Oncology 2014; 12(1) doi: 10.1186/1477-7819-12-192
|
| 28 |
Y. Choi, J. W. Kim, H. Cha, K. H. Han, J. Seong. Overall response of both intrahepatic tumor and portal vein tumor thrombosis is a good prognostic factor for hepatocellular carcinoma patients receiving concurrent chemoradiotherapy. Journal of Radiation Research 2014; 55(1): 113 doi: 10.1093/jrr/rrt082
|
| 29 |
Hong-Chi Jiang, Lian-Xin Liu, Da-Xun Piao, Jun Xu, Min Zheng, An-Long Zhu, Shu-Yi Qi, Wei-Hui Zhang, Lin-Feng Wu. Clinical short-term results of radiofrequency ablation in liver cancers. World Journal of Gastroenterology 2002; 8(4): 624-630 doi: 10.3748/wjg.v8.i4.624
|
| 30 |
Chenxi Xie, Xiaopei Hao, Hao Yuan, Chongyu Wang, Razinah Sharif, Haibo Yu. Crosstalk Between circRNA and Tumor Microenvironment of Hepatocellular Carcinoma: Mechanism, Function and Applications. OncoTargets and Therapy 2024; : 7 doi: 10.2147/OTT.S437536
|
| 31 |
Zu-Hua Gao. Predictive markers for postsurgical recurrence of hepatocellular carcinoma. Journal of Surgical Oncology 2005; 92(4): 274 doi: 10.1002/jso.20389
|
| 32 |
Runzhou Ni, Mingbing Xiao, Fei Jin, Cuihua Lu, Jiefei Huang, Xianyong Meng. Clinical value of hepatoma-specific alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Chinese Journal of Clinical Oncology 2006; 3(3): 153 doi: 10.1007/s11805-006-0109-x
|
| 33 |
Kosuke Matsui, Masaki Kaibori, Morihiko Ishizaki, A-Hon Kwon. Microwave coagulation therapy for huge hepatocellular carcinoma with liver cirhosis. Journal of Microwave Surgery 2011; 29: 127 doi: 10.3380/jmicrowavesurg.29.127
|
| 34 |
S. Jayaraman, A. Khakhar, H. Yang, D. Bainbridge, D. Quan. The association between central venous pressure, pneumoperitoneum, and venous carbon dioxide embolism in laparoscopic hepatectomy. Surgical Endoscopy 2009; 23(10): 2369 doi: 10.1007/s00464-009-0359-9
|
| 35 |
Rong‐Xin Chen, Yun‐Hong Xia, Jie‐Feng Cui, Tong‐Chun Xue, Sheng‐Long Ye. Osteopontin, a single marker for predicting the prognosis of patients with tumor‐node‐metastasis stage I hepatocellular carcinoma after surgical resection. Journal of Gastroenterology and Hepatology 2010; 25(8): 1435 doi: 10.1111/j.1440-1746.2010.06277.x
|
| 36 |
Feier Ding, Min Huang, Ping Ren, Junlei Zhang, Zhengyu Lin, Yan Sun, Changhu Liang, Xinya Zhao. Quantitative information from gadobenate dimeglumine-enhanced MRI can predict proliferative subtype of solitary hepatocellular carcinoma: a multicenter retrospective study. European Radiology 2023; 34(4): 2445 doi: 10.1007/s00330-023-10227-9
|
| 37 |
Yu Matsumoto, Yuichiro Otsuka, Rei Okada, Yuko Ito, Kazutaka Kimura, Jun Ishii, Tetsuya Maeda, Masaru Tsuchiya, Kimihiko Funahashi, Hideaki Shimada. Low serum creatine kinase level is associated with poor prognosis in patients with hepatocellular carcinoma: A retrospective single‑center study. Oncology Letters 2024; 28(4) doi: 10.3892/ol.2024.14587
|
| 38 |
D.S.R. Lockwood, D.C. Gotley. Integration/Interaction of Oncologic Growth. Cancer Growth and Progression 2005; 15: 165 doi: 10.1007/1-4020-3414-8_9
|
| 39 |
Lian-Xin Liu, Hong-Chi Jiang, Zhi-Hua Liu, Jing Zhou, Wei-Hui Zhang, An-Long Zhu, Xiu-Qin Wang, Min Wu. Intergrin gene expression profiles of humanhepatocellular carcinoma. World Journal of Gastroenterology 2002; 8(4): 631-637 doi: 10.3748/wjg.v8.i4.631
|
| 40 |
Hye Jin Heo, Yoonsang Park, Jung Hee Lee, Yujin Kim, Eun Kyoung Kim, Ga Hyun Kim, Yeuni Yu, So Youn Park, Hie Bum Seo, Kyoungjune Pak, Tae Sik Goh, Sehyeon Park, Sae-Ock Oh, Woosung Kwon, Yun Hak Kim. Clinical big-data-based design of GLUT2-targeted carbon nanodots for accurate diagnosis of hepatocellular carcinoma. Nanoscale 2022; 14(45): 17053 doi: 10.1039/D2NR04238J
|
| 41 |
Jae Gil Lee, Chang Mu Kang, Joon Seong Park, Kyung Sik Kim, Dong Sup Yoon, Jin Sub Choi, Woo Jung Lee, Byong Ro Kim. The Actual Five-year Survival Rate of Hepatocellular Carcinoma Patients after Curative Resection. Yonsei Medical Journal 2006; 47(1): 105 doi: 10.3349/ymj.2006.47.1.105
|
| 42 |
Zhenghong Xu, Zhiwen Zhang, Yi Chen, Lingli Chen, Liping Lin, Yaping Li. The characteristics and performance of a multifunctional nanoassembly system for the co-delivery of docetaxel and iSur-pDNA in a mouse hepatocellular carcinoma model. Biomaterials 2010; 31(5): 916 doi: 10.1016/j.biomaterials.2009.09.103
|
| 43 |
Xiaojie Xu, Chengying Jiang, Shibin Wang, Yanhong Tai, Tao Wang, Lei Kang, Zhongyi Fan, Shuyue Li, Ling Li, Jing Fu, Jiahong Liu, Quanbo Ji, Xuan Wang, Lixin Wei, Qinong Ye. HPIP is upregulated in liver cancer and promotes hepatoma cell proliferation via activation of G2/M transition. IUBMB Life 2013; 65(10): 873 doi: 10.1002/iub.1202
|
| 44 |
Priya Mathews, Danbi Lee, Young-Hwa Chung, Jeong A. Kim, Ju-Ho Lee, Young-Joo Jin, Wonhyung Park, Heather Lyu, Elizabeth Jaffee, Lei Zheng, Eunsil Yu, Young Joo Lee. Effects of Genomic Changes in Hepatitis B Virus on Postoperative Recurrence and Survival in Patients with Hepatocellular Carcinoma. Annals of Surgical Oncology 2013; 20(4): 1216 doi: 10.1245/s10434-012-2706-7
|
| 45 |
Run-Zhou Ni, Jie-Fei Huang, Ming-Bing Xiao, Mei Li, Xian-Yong Meng. Glycylproline dipeptidyl aminopeptidase isoenzyme in diagnosis of primary hepatocellular carcinoma. World Journal of Gastroenterology 2003; 9(4): 710-713 doi: 10.3748/wjg.v9.i4.710
|
| 46 |
Lian-Xin Liu, Hong-Chi Jiang, Da-Xun Piao. Radiofrequence ablation of liver cancers. World Journal of Gastroenterology 2002; 8(3): 393-399 doi: 10.3748/wjg.v8.i3.393
|
| 47 |
Charles E. Woodall, Charles R. Scoggins, Jennifer Loehle, Kadiyala V. Ravindra, Kelly M. McMasters, Robert C. G. Martin. Hepatic Imaging Characteristics Predict Overall Survival in Hepatocellular Carcinoma. Annals of Surgical Oncology 2007; 14(10): 2824 doi: 10.1245/s10434-007-9525-2
|
| 48 |
Yun-Le Wan, Shu-Sen Zheng, Zhi-Cheng Zhao, Min-Wei Li, Chang-Ku Jia, Hao Zhang. Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue, and its possible role in tumor immunity. World Journal of Gastroenterology 2004; 10(2): 195-199 doi: 10.3748/wjg.v10.i2.195
|
| 49 |
Wu Ji, Jie-Shou Li, Ling-Tang Li, Wu-Hong Liu, Kuan-Sheng Ma, Xiang-Tian Wang, Zhen-Ping He, Jia-Hong Dong. Role of preoperative selective portal vein embolization in two-step curative hepatectomy for hepatocellular carcinoma. World Journal of Gastroenterology 2003; 9(8): 1702-1706 doi: 10.3748/wjg.v9.i8.1702
|
| 50 |
Zhao-Chong Zeng, Zhao-You Tang, Jia Fan, Jian Zhou, Lun-Xiu Qin, Shen-Long Ye, Hui-Chuan Sun, Bin-Liang Wang, Yao Yu, Jian-Hua Wang, Wei Guo. A Comparison of Chemoembolization Combination With and Without Radiotherapy for Unresectable Hepatocellular Carcinoma. The Cancer Journal 2004; 10(5): 307 doi: 10.1097/00130404-200409000-00008
|
| 51 |
Ali Zarrinpar, Un Bi Kim, Vijay Boominathan. Phenotypic Response and Personalized Medicine in Liver Cancer and Transplantation: Approaches to Complex Systems. Advanced Therapeutics 2020; 3(4) doi: 10.1002/adtp.201900167
|
| 52 |
Chang-Xin Geng, Zhao-Chong Zeng, Ji-Yao Wang. Docetaxel inhibits SMMC-7721 human hepatocellular carcinoma cells growth and induces apoptosis. World Journal of Gastroenterology 2003; 9(4): 696-700 doi: 10.3748/wjg.v9.i4.696
|
| 53 |
Myeong Jun Song, Chan Kwon Jung, Chung‐Hwa Park, Wonhee Hur, Jung Eun Choi, Si Hyun Bae, Jong Young Choi, Sang Wook Choi, Nam Ik Han, Seung Kew Yoon. RPL36 as a prognostic marker in hepatocellular carcinoma. Pathology International 2011; 61(11): 638 doi: 10.1111/j.1440-1827.2011.02716.x
|
| 54 |
Shao-Shan Wang, Ti Zhang, Xi-Lu Wang, Li Hong, Qing-Hui Qi. Effect of arsenic trioxide on rat hepatocarcinoma and its renal cytotoxicity. World Journal of Gastroenterology 2003; 9(5): 930-935 doi: 10.3748/wjg.v9.i5.930
|
| 55 |
Wen-Hua Xiao, Wei-Wen Liu. Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma. World Journal of Gastroenterology 2004; 10(3): 376-380 doi: 10.3748/wjg.v10.i3.376
|
| 56 |
Dafina Nikolova, Viktorija Chalovska, Magdalena Genadieva Ivanova, Emilija Nikolovska, Ance Volkanovska, Nikola Orovchanec, Slavica Kostadinova Kunovska, Gordana Petrushevska, Vesna Janevska. Immunohistochemical Expression of Epidermal Growth Factor Receptor in Hepatocellular Carcinoma. PRILOZI 2018; 39(2-3): 21 doi: 10.2478/prilozi-2018-0038
|
| 57 |
Archana Rastogi. Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(35): 4000-4013 doi: 10.3748/wjg.v24.i35.4000
|
| 58 |
Benoit Schmauch, Sarah S. Elsoukkary, Amika Moro, Roma Raj, Chase J. Wehrle, Kazunari Sasaki, Julien Calderaro, Patrick Sin-Chan, Federico Aucejo, Daniel E. Roberts. Combining a deep learning model with clinical data better predicts hepatocellular carcinoma behavior following surgery. Journal of Pathology Informatics 2023; : 100360 doi: 10.1016/j.jpi.2023.100360
|
| 59 |
Hu Liu, Sheng-Long Ye, Jiong Yang, Zhao-You Tang, Yin-Kun Liu, Lun-Xiu Qin, Shuang-Jian Qiu, Rui-Xia Sun. The microcell mediated transfer of human chromosome 8 into highly metastatic rat liver cancer cell line C5F. World Journal of Gastroenterology 2003; 9(3): 449-453 doi: 10.3748/wjg.v9.i3.449
Abstract(938) |
Core Tip(743) |
Full Article(HTML)(2213)
|
Full Article (PDF)-375K(290)
|
Times Cited (0)
|
Total Visits (4627)
|
Open
|
| 60 |
Shu-Min Zhang, Zhao-Chong Zeng, Zhao-You Tang, Jing Sun, Jie-Min Cheng, Rong Liu, Ping Wang, Bo-Heng Zhang. Prognostic analysis of pulmonary metastases from hepatocellular carcinoma. Hepatology International 2008; 2(2): 237 doi: 10.1007/s12072-008-9052-7
|
| 61 |
Kenji Kashima, Miho Watanabe, Yasuko Satoh, Junichi Hata, Nobuya Ishii, Yuko Aoki. Inhibition of lymphatic metastasis in neuroblastoma by a novel neutralizing antibody to vascular endothelial growth factor‐D. Cancer Science 2012; 103(12): 2144 doi: 10.1111/cas.12010
|
| 62 |
Luca Di Tommaso, Marco Spadaccini, Matteo Donadon, Nicola Personeni, Abubaker Elamin, Alessio Aghemo, Ana Lleo. Role of liver biopsy in hepatocellular carcinoma. World Journal of Gastroenterology 2019; 25(40): 6041-6052 doi: 10.3748/wjg.v25.i40.6041
|
| 63 |
Yifan Li, Qiaozhen Zhu, Shuchang Zhou, Jiangtao Chen, Aoyu Du, Changjiang Qin. Combined bulk RNA and single-cell RNA analyses reveal TXNL4A as a new biomarker for hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1202732
|
| 64 |
Mei-Sze Chua, Hongbo Sun, Siu T Cheung, Veronica Mason, John Higgins, Douglas T Ross, Sheung T Fan, Samuel So. Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Modern Pathology 2007; 20(1): 76 doi: 10.1038/modpathol.3800711
|
| 65 |
Hui-Ting Hsu, Pei-Ru Wu, Chih-Jung Chen, Li-Sung Hsu, Chung-Min Yeh, Ming-Tai Hsing, Yi-Shan Chiang, Ming-Tsung Lai, Kun-Tu Yeh. High Cytoplasmic Expression of Krüppel-like Factor 4 Is an Independent Prognostic Factor of Better Survival in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2014; 15(6): 9894 doi: 10.3390/ijms15069894
|
| 66 |
Wei Wang, Lian-Yue Yang, Zhi-Li Yang, Gen-Wen Huang, Wei-Qun Lu. Expression and significance of RhoC gene in hepatocellular carcinoma. World Journal of Gastroenterology 2003; 9(9): 1950-1953 doi: 10.3748/wjg.v9.i9.1950
|
| 67 |
Jun-Fei Jin, Liu-Di Yuan, Li Liu, Zhu-Jiang Zhao, Wei Xie. Preparation and characterization of polyclonal antibodies against ARL-1 protein. World Journal of Gastroenterology 2003; 9(7): 1455-1459 doi: 10.3748/wjg.v9.i7.1455
|
| 68 |
Ferenc Szalay, Mónika B Hantos, Andrea Horvath, Peter L. Lakatos, Aniko Folhoffer, Kinga Dunkel, Dalma Hegedus, Kornélia Tekes. Increased nociceptin/orphanin FQ plasma levels in hepatocellular carcinoma. World Journal of Gastroenterology 2004; 10(1): 42-45 doi: 10.3748/wjg.v10.i1.42
|
| 69 |
Jun Qian, Gan-Sheng Feng, Thomas Vogl. Combined interventional therapies of hepatocellular carcinoma. World Journal of Gastroenterology 2003; 9(9): 1885-1891 doi: 10.3748/wjg.v9.i9.1885
|
| 70 |
Noriaki Morofuji, Hidenori Ojima, Nobuyoshi Hiraoka, Takuji Okusaka, Minoru Esaki, Satoshi Nara, Kazuaki Shimada, Yoshiro Kishi, Tadashi Kondo. Antibody-based proteomics to identify an apoptosis signature for early recurrence of hepatocellular carcinoma. Clinical Proteomics 2016; 13(1) doi: 10.1186/s12014-016-9130-0
|
| 71 |
Ignasia Andhini Retnowulan, Marini Stephanie, Nur Rahadiani, Ridho Ardhi Syaiful, Ening Krisnuhoni. Hepatocellular Carcinoma's Characteristics in an Endemic Country: A Closer Examination of Tumor Grade and Microvascular Invasion. Siriraj Medical Journal 2023; 75(11): 817 doi: 10.33192/smj.v75i11.264786
|
| 72 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_6-1
|
| 73 |
2023 Update of Indian National Association for Study of the Liver Consensus on Management of Intermediate and Advanced Hepatocellular Carcinoma: The Puri III Recommendations. Journal of Clinical and Experimental Hepatology 2024; 14(1): 101269 doi: 10.1016/j.jceh.2023.08.005
|
| 74 |
Pawan Tekchandani, Balak Das Kurmi, Rishi Paliwal, Shivani Rai Paliwal. Galactosylated TPGS Micelles for Docetaxel Targeting to Hepatic Carcinoma: Development, Characterization, and Biodistribution Study. AAPS PharmSciTech 2020; 21(5) doi: 10.1208/s12249-020-01690-4
|
| 75 |
Zhenzhen Su, Limei Luo, Xiaojuan Wu, Bin Wei, Lu Wang, Fei Liu, Bei Cai. Association of the MARCO polymorphism rs6761637 with hepatocellular carcinoma susceptibility and clinical characteristics. Immunologic Research 2022; 70(3): 400 doi: 10.1007/s12026-022-09271-2
|
| 76 |
Ameya Patil, Rebecca Salvatori, Lindsey Smith, Sarah M Jenkins, Andrew Cannon, Christopher P Hartley, Rondell P Graham, Roger K Moreira. Artificial intelligence‐based reticulin proportionate area – a novel histological outcome predictor in hepatocellular carcinoma. Histopathology 2023; 83(4): 512 doi: 10.1111/his.15001
|
| 77 |
Quan-Da Liu, Kuan-Sheng Ma, Zhen-Ping He, Jun Ding, Xue-Quan Huang, Jia-Hong Dong. Experimental study on the feasibility and safety of radiofrequency ablation for secondary splenomagely and hypersplenism. World Journal of Gastroenterology 2003; 9(4): 813-817 doi: 10.3748/wjg.v9.i4.813
|
| 78 |
Lian-yue Yang, Wei-qun Lu, Geng-wen Huang, Wei Wang. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma. BMC Cancer 2006; 6(1) doi: 10.1186/1471-2407-6-110
|
| 79 |
Junichi Zaitsu, Takahiro Yamasaki, Issei Saeki, Yohei Harima, Takuya Iwamoto, Yumiko Harima, Toshihiko Matsumoto, Yohei Urata, Isao Hidaka, Yoshio Marumoto, Tsuyoshi Ishikawa, Taro Takami, Naoki Yamamoto, Seiji Kaino, Koichi Uchida, Shuji Terai, Isao Sakaida. Serum transferrin as a predictor of prognosis for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma. Hepatology Research 2014; 44(5): 481 doi: 10.1111/hepr.12141
|
| 80 |
Yu Lei, Qiaoling Hu, Jiang Gu. Expressions of Carbohydrate Response Element Binding Protein and Glucose Transporters in Liver Cancer and Clinical Significance. Pathology & Oncology Research 2020; 26(2): 1331 doi: 10.1007/s12253-019-00708-y
|
| 81 |
Chenfeng Xu, Yu Ding, Jiang Ni, Lifang Yin, Jianping Zhou, Jing Yao. Tumor-targeted docetaxel-loaded hyaluronic acid-quercetin polymeric micelles with p-gp inhibitory property for hepatic cancer therapy. RSC Advances 2016; 6(33): 27542 doi: 10.1039/C6RA00460A
|
| 82 |
WILLIAM KEMP, STEPHEN PIANKO, SHARA NGUYEN, MICHAEL J BAILEY, STUART K ROBERTS. Survival in hepatocellular carcinoma: Impact of screening and etiology of liver disease. Journal of Gastroenterology and Hepatology 2005; 20(6): 873 doi: 10.1111/j.1440-1746.2005.03844.x
|
| 83 |
Yi Jilin, Tian Geng. Gene cloning of murine α-fetoprotein gene and construction of its eukaryotic expression vector and expression in CHO cells. Current Medical Science 2003; 23(4): 392 doi: 10.1007/BF02829426
|
| 84 |
Haixiao Wang, Kuangjie Wu, Yuan Sun, Yandong Li, Mingyu Wu, Qian Qiao, Yuanjiang Wei, Ze-Guang Han, Bing Cai. STC2 is upregulated in hepatocellular carcinoma and promotes cell proliferation and migration in vitro. BMB Reports 2012; 45(11): 629 doi: 10.5483/BMBRep.2012.45.11.086
|
| 85 |
Dao-Yong Liu, Zhi-Hai Peng, Guo-Qiang Qiu, Chong-Zhi Zhou. Expression of telomerase activity and oxidative stress in human hepatocellular carcinoma with cirrhosis. World Journal of Gastroenterology 2003; 9(8): 1859-1862 doi: 10.3748/wjg.v9.i8.1859
|
| 86 |
Yu-Chen Hsu, Hsiao-Hui Fu, Yung-Ming Jeng, Po-Huang Lee, Shiaw-Der Yang. Proline-Directed Protein Kinase FA Is a Powerful and Independent Prognostic Predictor for Progression and Patient Survival of Hepatocellular Carcinoma. Journal of Clinical Oncology 2006; 24(23): 3780 doi: 10.1200/JCO.2005.03.7499
|
| 87 |
Dong Xu, De-Ying Tian, Zhen-Gang Zhang, Hong-Yun Chen, Pei-Hui Song. Effect of SEN virus coinfection on outcome of lamivudine therapy in patients with hepatitis B. World Journal of Gastroenterology 2004; 10(7): 968-971 doi: 10.3748/wjg.v10.i7.968
|
| 88 |
Salvatore Lorenzo Renne, Samantha Sarcognato, Diana Sacchi, Maria Guido, Massimo Roncalli, Luigi Terracciano, Luca Di Tommaso. Hepatocellular carcinoma: a clinical and pathological overview. Pathologica 2021; 113(3): 203 doi: 10.32074/1591-951X-295
|
| 89 |
Ning Ren, Lun-Xiu Qin, Hong Tu, Yin-Kun Liu, Bo-Heng Zhang, Zhao-You Tang. The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2006; 132(6): 399 doi: 10.1007/s00432-005-0049-5
|
| 90 |
Zimin Liu, Huamin Liu, Huazheng Pan, Qihang Du, Jun Liang. Clinicopathological significance of S100A4 expression in human hepatocellular carcinoma. Journal of International Medical Research 2013; 41(2): 457 doi: 10.1177/0300060513478086
|
| 91 |
Takayuki Shimizu, Mitsuru Ishizuka, Takashi Suzuki, Genki Tanaka, Kyung Hwa Park, Takatsugu Matsumoto, Takayuki Shiraki, Yuhki Sakuraoka, Masato Kato, Taku Aoki, Keiichi Kubota. The preoperative globulin‐to‐albumin ratio, a novel inflammation‐based prognostic system, predicts survival after potentially curative liver resection for patients with hepatocellular carcinoma. Journal of Surgical Oncology 2017; 116(8): 1166 doi: 10.1002/jso.24772
|
| 92 |
Young Kon Kim, Hyo Sung Kwak, Chong Soo Kim, Gyung Ho Chung, Young Min Han, Jeong Min Lee. Hepatocellular Carcinoma in Patients with Chronic Liver Disease: Comparison of SPIO-enhanced MR Imaging and 16–Detector Row CT. Radiology 2006; 238(2): 531 doi: 10.1148/radiol.2381042193
|
| 93 |
Luciana dos Santos Schraiber, Angelo Alves de Mattos, Maria Lucia Zanotelli, Guido Pio Cracco Cantisani, Ajácio Bandeira de Mello Brandão, Cludio Augusto Marroni, Guilhermo Kiss, Lucas Ernani, Patrícia dos Santos Marcon. Alpha-fetoprotein Level Predicts Recurrence After Transplantation in Hepatocellular Carcinoma. Medicine 2016; 95(3): e2478 doi: 10.1097/MD.0000000000002478
|
| 94 |
Zhan-Hong Chen, Ying-Fen Hong, Jinxiang Lin, Xing Li, Dong-Hao Wu, Jing-Yun Wen, Jie Chen, Dan-Yun Ruan, Qu Lin, Min Dong, Li Wei, Tian-Tian Wang, Ze-Xiao Lin, Xiao-Kun Ma, Xiang-Yuan Wu, Ruihua Xu. Validation and ranking of seven staging systems of hepatocellular carcinoma. Oncology Letters 2017; 14(1): 705 doi: 10.3892/ol.2017.6222
|
| 95 |
Yun-peng Hao, Zheng-yu Liu, Cheng Xie, Lu Zhou, Xun Sun. Novel fluorinated docetaxel analog for anti-hepatoma: Molecular docking and biological evaluation. European Journal of Pharmaceutical Sciences 2016; 88: 274 doi: 10.1016/j.ejps.2016.03.022
|
| 96 |
Shi-Jian Ding, Yan Li, Ye-Xiong Tan, Man-Rong Jiang, Bo Tian, Ying-Kun Liu, Xiao-Xia Shao, Sheng-Long Ye, Jia-Rui Wu, Rong Zeng, Hong-Yang Wang, Zhao-You Tang, Qi-Chang Xia. From Proteomic Analysis to Clinical Significance. Molecular & Cellular Proteomics 2004; 3(1): 73 doi: 10.1074/mcp.M300094-MCP200
|
| 97 |
Tomohiro Iguchi, Shinichi Aishima, Kensaku Sanefuji, Nobuhiro Fujita, Keishi Sugimachi, Tomonobu Gion, Akinobu Taketomi, Ken Shirabe, Yoshihiko Maehara, Masazumi Tsuneyoshi. Both Fibrous Capsule Formation and Extracapsular Penetration Are Powerful Predictors of Poor Survival in Human Hepatocellular Carcinoma: A Histological Assessment of 365 Patients in Japan. Annals of Surgical Oncology 2009; 16(9): 2539 doi: 10.1245/s10434-009-0453-1
|
| 98 |
Brian I. Carr, Petr Pancoska, Edoardo G. Giannini, Fabio Farinati, Francesca Ciccarese, Gian Ludovico Rapaccini, Maria Di Marco, Luisa Benvegnù, Marco Zoli, Franco Borzio, Eugenio Caturelli, Maria Chiaramonte, Franco Trevisani. Identification of Two Clinical Hepatocellular Carcinoma Patient Phenotypes From Results of Standard Screening Parameters. Seminars in Oncology 2014; 41(3): 406 doi: 10.1053/j.seminoncol.2014.04.002
|
| 99 |
Chih H Cheng, Chen F Lee, Tsung H Wu, Kun M Chan, Hong S Chou, Ting J Wu, Ming C Yu, Tse C Chen, Wei C Lee, Miin F Chen. Evaluation of the new AJCC staging system for resectable hepatocellular carcinoma. World Journal of Surgical Oncology 2011; 9(1) doi: 10.1186/1477-7819-9-114
|
| 100 |
Pierre Bedossa, Valérie Paradis. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. 2012; : 1223 doi: 10.1016/B978-1-4377-1454-8.00078-3
|
| 101 |
Armin Thelen, Arne Scholz, Christoph Benckert, Zofia von Marschall, Maik Schröder, Bertram Wiedenmann, Peter Neuhaus, Stefan Rosewicz, Sven Jonas. VEGF‐D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinoma. International Journal of Cancer 2008; 122(11): 2471 doi: 10.1002/ijc.23439
|
| 102 |
Zenta Walther, Dhanpat Jain. Molecular Pathology of Hepatic Neoplasms: Classification and Clinical Significance. Pathology Research International 2011; 2011: 1 doi: 10.4061/2011/403929
|
| 103 |
O Scatton, F Chiappini, P Riou, A Marconi, R Saffroy, M-P Bralet, D Azoulay, C Boucheix, B Debuire, G Uzan, A Lemoine. Fate and characterization of circulating tumor cells in a NOD/SCID mouse model of human hepatocellular carcinoma. Oncogene 2006; 25(29): 4067 doi: 10.1038/sj.onc.1209430
|
| 104 |
Lunxiu Qin, Zhaoyou Tang, Xinyuan Guan, Qinghai Ye, Huliang Jia, Ning Ren. The predictive value of chromosome 8p deletion for metastasis of hepatocellular carcinoma: a summary of works in 10 years. Frontiers of Medicine in China 2008; 2(3): 211 doi: 10.1007/s11684-008-0041-y
|
| 105 |
Xiu-Tao Fu, Zheng Tang, Jia-Feng Chen, Ying-Hong Shi, Wei-Ren Liu, Qiang Gao, Guang-Yu Ding, Kang Song, Xiao-Ying Wang, Jian Zhou, Jia Fan, Zhen-Bin Ding. Laparoscopic hepatectomy enhances recovery for small hepatocellular carcinoma with liver cirrhosis by postoperative inflammatory response attenuation: a propensity score matching analysis with a conventional open approach. Surgical Endoscopy 2021; 35(2): 910 doi: 10.1007/s00464-020-07710-5
|
| 106 |
Yannick M. Meyer, Berend R. Beumer, Diederik J. Höppener, Pieter M.H. Nierop, Michail Doukas, Roeland F. de Wilde, Dave Sprengers, Peter B. Vermeulen, Cornelis Verhoef, Jan N.M. IJzermans. Histopathological growth patterns modify the prognostic impact of microvascular invasion in non-cirrhotic hepatocellular carcinoma. HPB 2022; 24(4): 507 doi: 10.1016/j.hpb.2021.07.009
|
| 107 |
Atsushi Nanashima, Syuuichi Tobinaga, Masaki Kunizaki, Satoshi Miuma, Naota Taura, Hiroaki Takeshita, Shigekazu Hidaka, Terumitsu Sawai, Kazuhiko Nakao, Takeshi Nagayasu. Strategy of treatment for hepatocellular Carcinomas with vascular infiltration in patients undergoing hepatectomy. Journal of Surgical Oncology 2010; 101(7): 557 doi: 10.1002/jso.21534
|
| 108 |
Ruo-Cai Xu, Han-Chun Liu, Jian-Liang Li, Ke Li, Shuang-Yan Ou, Zhi-Yuan Yu, Yi Kong, Guo-An Ma, Wei-Shu Shao. Long-term outcome of transcatheter arterial chemoembolization after radiofrequency ablation as a combined therapy for Chinese patients with hepatocellular carcinoma. Current Medical Research and Opinion 2015; 31(8): 1553 doi: 10.1185/03007995.2015.1058249
|
| 109 |
Diagnostic Pathology: Hepatobiliary and Pancreas. 2017; : 276 doi: 10.1016/B978-0-323-44307-4.50094-4
|
| 110 |
Ming-Chin Yu, Kun-Ming Chan, Chen-Fang Lee, Yun-Shien Lee, Firas Zahr Eldeen, Hong-Shiue Chou, Wei-Chen Lee, Miin-Fu Chen. Alkaline Phosphatase: Does it have a Role in Predicting Hepatocellular Carcinoma Recurrence?. Journal of Gastrointestinal Surgery 2011; 15(8): 1440 doi: 10.1007/s11605-011-1537-3
|
| 111 |
Yun Hak Kim, Dae Cheon Jeong, Kyoungjune Pak, Myoung-Eun Han, Ji-Young Kim, Liu Liangwen, Hyun Jin Kim, Tae Woo Kim, Tae Hwa Kim, Dong Woo Hyun, Sae-Ock Oh. SLC2A2 (GLUT2) as a novel prognostic factor for hepatocellular carcinoma. Oncotarget 2017; 8(40): 68381 doi: 10.18632/oncotarget.20266
|
| 112 |
Pierre Bedossa, Valérie Paradis. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; : 1272 doi: 10.1016/B978-0-323-34062-5.00089-3
|
| 113 |
Yiyu Lu, Zhaoyuan Fang, Meiyi Li, Qian Chen, Tao Zeng, Lina Lu, Qilong Chen, Hui Zhang, Qianmei Zhou, Yan Sun, Xuefeng Xue, Yiyang Hu, Luonan Chen, Shibing Su, Jiarui Wu. Dynamic edge-based biomarker non-invasively predicts hepatocellular carcinoma with hepatitis B virus infection for individual patients based on blood testing. Journal of Molecular Cell Biology 2019; 11(8): 665 doi: 10.1093/jmcb/mjz025
|
| 114 |
Eun Shin, Han Suk Ryu, Soo‐Hee Kim, Haeyoen Jung, Ja‐June Jang, Kyoungbun Lee. The clinicopathological significance of heat shock protein 70 and glutamine synthetase expression in hepatocellular carcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2011; 18(4): 544 doi: 10.1007/s00534-010-0367-0
|
| 115 |
MASATAKE TANAKA, YUKO MASAKI, KOSUKE TANAKA, MASAYUKI MIYAZAKI, MASAKI KATO, RIE SUGIMOTO, KAZUHIKO NAKAMURA, SHINICHI AISHIMA, KEN SHIRABE, MAKOTO NAKAMUTA, MUNECHIKA ENJOJI, KAZUHIRO KOTOH, RYOICHI TAKAYANAGI. Reduction of fatty acid oxidation and responses to hypoxia correlate with the progression of de-differentiation in HCC. Molecular Medicine Reports 2013; 7(2): 365 doi: 10.3892/mmr.2012.1201
|
| 116 |
Vito Longo, Oronzo Brunetti, Stella D’Oronzo, Carmela Ostuni, Pietro Gatti, Franco Silvestris. Bone metastases in hepatocellular carcinoma: an emerging issue. Cancer and Metastasis Reviews 2014; 33(1): 333 doi: 10.1007/s10555-013-9454-4
|
| 117 |
Fu-Hua Yan, Kang-Rong Zhou, Jie-Min Cheng, Jian-Hua Wang, Zhi-Ping Yan, Reng-Rong Da, Jia Fan, Yuan Ji. Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE. World Journal of Gastroenterology 2002; 8(4): 658-662 doi: 10.3748/wjg.v8.i4.658
|
| 118 |
Aziz Zaanan, Nicolas Williet, Mohamed Hebbar, Tienhan Sandrine Dabakuyo, Laetitia Fartoux, Touraj Mansourbakht, Olivier Dubreuil, Olivier Rosmorduc, Stéphane Cattan, Franck Bonnetain, Valérie Boige, Julien Taïeb. Gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma: A large multicenter AGEO study. Journal of Hepatology 2013; 58(1): 81 doi: 10.1016/j.jhep.2012.09.006
|
| 119 |
Chen-Guo Ker, Hong-Yaw Chen, Hsi-Jung Chen, I-Hao Tseng, Yu-Jou Tsai, Hoi-Wan Lo, Chung-Chou Juan. Challenge of safety margin in laparoscopic liver resection for hepatocellular carcinoma. Formosan Journal of Surgery 2014; 47(5): 183 doi: 10.1016/j.fjs.2014.08.005
|
| 120 |
Xiao-Bo Man, Liang Tang, Xiu-Hua Qiu, Li-Qun Yang, Hui-Fang Cao, Meng-Chao Wu, Hong-Yang Wang. Expression of <italic>cytochrome P4502E1</italic> gene in hepatocellular carcinoma. World Journal of Gastroenterology 2004; 10(11): 1565-1568 doi: 10.3748/wjg.v10.i11.1565
|
| 121 |
Ke-Jun Nan, Zhao Jing, Ling Gong. Expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27<sup>Kip1</sup> in hepatocellular carcinoma. World Journal of Gastroenterology 2004; 10(10): 1425-1430 doi: 10.3748/wjg.v10.i10.1425
|
| 122 |
Yong Li, Feifan Zhou, Fang Liu, Meng Wang, Wenge Xing. Experimental Study on Evaluation of Blood Supply Level and Embolization Ratio of Liver Cancer Based on I-Flow Software. Technology in Cancer Research & Treatment 2020; 19 doi: 10.1177/1533033820970665
|
| 123 |
Chen-Guo Ker. Surgical safety margin of gastroenterological cancer surgery: A truth or a dream?. Formosan Journal of Surgery 2014; 47(3): 83 doi: 10.1016/j.fjs.2013.07.004
|
| 124 |
A. ZIMMERMANN. Surgery of the Liver, Biliary Tract and Pancreas. 2007; : 1085 doi: 10.1016/B978-1-4160-3256-4.50082-X
|
| 125 |
Lei Xu, Shuo Wu, Jun Wang. Cancer cell membrane–coated nanocarriers for homologous target inhibiting the growth of hepatocellular carcinoma. Journal of Bioactive and Compatible Polymers 2019; 34(1): 58 doi: 10.1177/0883911518819107
|
| 126 |
Chen Liu, Xuan-Yu Huang, Yun Huang. FAM83G promotes proliferation, invasion, and metastasis by regulating PI3K/AKT signaling in hepatocellular carcinoma cells. Biochemical and Biophysical Research Communications 2021; 567: 63 doi: 10.1016/j.bbrc.2021.05.081
|
| 127 |
Shama C. Buch, Venkateswarlu Kondragunta, Robert A. Branch, Brian I. Carr. Gender-based outcomes differences in unresectable hepatocellular carcinoma. Hepatology International 2008; 2(1): 95 doi: 10.1007/s12072-007-9041-2
|
| 128 |
Frank Tacke, Georg Brabant, Elmar Kruck, Rüdiger Horn, Patrick Schöffski, Hartmut Hecker, Michael P Manns, Christian Trautwein. Ghrelin in chronic liver disease. Journal of Hepatology 2003; 38(4): 447 doi: 10.1016/S0168-8278(02)00438-5
|
| 129 |
Lei Xu, Shuo Wu, Xiaoqiu Zhou. Bioinspired nanocarriers for an effective chemotherapy of hepatocellular carcinoma. Journal of Biomaterials Applications 2018; 33(1): 72 doi: 10.1177/0885328218772721
|
| 130 |
Kuo-Feng Hsu, Jyh-Cherng Yu, Chih-Wei Yang, Bao-Chung Chen, Cheng-Jueng Chen, De-Chuan Chan, Hsiu-Lung Fan, Teng-Wei Chen, Yu-Lueng Shih, Tsai-Yuan Hsieh, Chung-Bao Hsieh. Long-term outcomes in elderly patients with resectable large hepatocellular carcinoma undergoing hepatectomy. Surgical Oncology 2018; 27(3): 595 doi: 10.1016/j.suronc.2018.07.009
|
| 131 |
Yujing Ma, Shaobo Duan, Shanshan Ren, Didi Bu, Yahong Li, Xiguo Cai, Lianzhong Zhang. Machine learning based ultrasomics noninvasive predicting EGFR expression status in hepatocellular carcinoma patients. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1483291
|
| 132 |
Zhen-Yu Yin, Xiao-Ming Wang, Ren-Xiang Yu, Bai-Meng Zhang, Ke-Ke Yu, Ning Li, Jie-Shou Li. Total vascular exclusion technique for resection of hepatocellular carcinoma. World Journal of Gastroenterology 2003; 9(10): 2194-2197 doi: 10.3748/wjg.v9.i10.2194
|
| 133 |
Young Kon Kim, Young Hwan Lee, Chong Soo Kim, Young Min Han, Seung Bae Hwang. Double-dose 1.0-M gadobutrol versus standard-dose 0.5-M gadopentetate dimeglumine in revealing small hypervascular hepatocellular carcinomas. European Radiology 2008; 18(1): 70 doi: 10.1007/s00330-007-0630-1
|
| 134 |
Xiao‐Hui Huang, Qian Wang, Jing‐Song Chen, Xin‐Hui Fu, Xi‐Lin Chen, Lian‐Zhou Chen, Wen Li, Jiong Bi, Long‐Juan Zhang, Qian Fu, Wen‐Tao Zeng, Liang‐Qi Cao, Hao‐Xiang Tan, Qiao Su. Bead‐based microarray analysis of microRNA expression in hepatocellular carcinoma: miR‐338 is downregulated. Hepatology Research 2009; 39(8): 786 doi: 10.1111/j.1872-034X.2009.00502.x
|
| 135 |
Lun-Xiu Qin, Zhao-You Tang. The prognostic molecular markers in hepatocellular carcinoma. World Journal of Gastroenterology 2002; 8(3): 385-392 doi: 10.3748/wjg.v8.i3.385
|
| 136 |
Diego F. Calvisi, Valentina M. Factor, Sara Ladu, Elizabeth A. Conner, Snorri S. Thorgeirsson. Disruption of β-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice. Gastroenterology 2004; 126(5): 1374 doi: 10.1053/j.gastro.2004.02.014
|
| 137 |
Zhenghong Xu, Lingli Chen, Wangwen Gu, Yu Gao, Liping Lin, Zhiwen Zhang, Yong Xi, Yaping Li. The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials 2009; 30(2): 226 doi: 10.1016/j.biomaterials.2008.09.014
|
| 138 |
Neelam Shah, Saurabh Katawale, Sanket Shah, Vivek Dhawan, Mangal Nagarsenker. Exploring Palmitoylated Arabinogalactan in Solid Lipid Nanoparticles: Formulation Design and in vitro Assessment for Hepatospecific Targeting. Drug Delivery Letters 2023; 13(2): 92 doi: 10.2174/2210303113666230202153647
|
| 139 |
Antonio Moral, José Magarzo. Marcadores tumorales serológicos en cirugía hepatobiliopancreática. Cirugía Española 2004; 76(5): 276 doi: 10.1016/S0009-739X(04)72378-7
|